National Cancer Institute Bestows Highest Rating on The Ohio State University

COLUMBUS, Ohio (January 31, 2011) – The National Cancer Institute (NCI) has awarded The Ohio State University Comprehensive Cancer Center the highest possible rating – “exceptional” – after completing its scientific peer review of the University’s cancer program. Located in Columbus, The Ohio State University Comprehensive Cancer Center includes the James Cancer Hospital and Solove Research Institute along with more than 250 cancer researchers representing a vast number of disciplines from 13 of the 18 colleges at Ohio State.

This action renews the Ohio State University’s designation as an NCI Comprehensive Cancer Center for at least another five years.  This rating and re-designation came after a thorough review by a 28-member peer-review panel appointed by the NCI of Ohio State’s nearly 1,500-page application and a three-day site visit in May 2010. The panel deemed Ohio State’s Comprehensive Cancer Center as “the model for other matrix university-based centers.” 

The NCI’s panel of reviewers noted that there has been “substantial improvement in every dimension of this cancer center. The remarkable growth is highlighted in the impressive trajectory of high-impact publications, NCI support, (and several) multi-investigator grants…along with the recruitment of 159 cancer-focused investigators in key areas that will provide new and exciting research opportunities.”

“The Ohio State University Comprehensive Cancer Center has made extraordinary progress in building a broad range of exceptional research programs which spans cancer research from basic science to prevention. It now takes its place as one of the preeminent cancer centers in the country,” said Dr. Robert C. Young, president of RCYMedicine and chairman of the External Advisory Board of Ohio State’s Comprehensive Cancer Center. Young also is a past president and CEO of Fox Chase Comprehensive Cancer Center and former Chair of the NCI Board of Scientific Advisors.

“This is further validation of our cancer research efforts to translate discoveries into leading edge therapies that prevent, detect, treat and cure cancer,” stated Dr. Michael A. Caligiuri, director of The Ohio State University Comprehensive Cancer Center and CEO of The James Cancer Hospital and Solove Research Institute.  “By harnessing the depth and breadth of our university, researchers from multiple colleges and disciplines throughout Ohio State collaborate to bring new knowledge to the world on how we understand, treat and cure cancer. It is because of this collaboration – and the ongoing institutional support and commitment from the University – that this stellar score and recognition are made possible.”

The OSUCCC was first designated as an NCI-designated Comprehensive Cancer Center in 1976. The classification requires competitive renewal every five years.

“Combined with an exemplary record of institutional support, this accomplishment testifies to the unwavering commitment that our physicians, faculty, staff and the talented leadership team of the Comprehensive Cancer Center have made to discovering more effective ways to prevent, detect and treat cancer,” said E. Gordon Gee, president of The Ohio State University.  “Ohio State is unique in bringing to bear the broadest possible range of disciplines in the fight against this disease.  Because of that dedication and academic breadth, we are able to change the lives of patients and their families, from throughout Ohio and around the world.”

Related Articles

OSU Cancer Center Told It’s Among Best in U.S.
Columbus Dispatch (Front page)
1/30

Dr. Michael Caligiuri is one proud man. The director of Ohio State University’s Comprehensive Cancer Center recently got word that his institution has earned the equivalent of straight A’s for research. Even better, those grades carry with them the hope that a $60 million check will follow. The National Cancer Institute reviews the nation’s cancer-research centers every five years and gives them a score based on several factors.

Dispatch story: http://bit.ly/fk7Gli

Comprehensive Cancer Center Lauded
The Columbus Dispatch (Editorial)
2/1

Ohio State University's Comprehensive Cancer Center proves what is possible when foresight, hard work and community support fuse over decades: OSU ranks among the best in the nation at research helping to prevent, treat and cure patients with the devastating disease. The bragging rights are all the better because the award stems from an expert peer review by the National Cancer Institute. The distinction validates OSU's research efforts to translate discoveries into leading-edge therapies, said Dr. Michael A. Caligiuri, director of the Comprehensive Cancer Center, whose leadership helped the center achieve this milestone.

Dispatch: http://bit.ly/fJHbIT

NCI Bestows Highest Rating on OSU Cancer Center
The Circleville Herald
HealthNewsDigest.com (17,000 monthly visitors)
2/1

The National Cancer Institute (NCI) has awarded The Ohio State University Comprehensive Cancer Center the highest possible rating – “exceptional” – after completing its scientific peer review of the University’s cancer program. Located in Columbus, The Ohio State University Comprehensive Cancer Center includes the James Cancer Hospital and Solove Research Institute along with more than 250 cancer researchers representing a vast number of disciplines from 13 of the 18 colleges at Ohio State.

HealthNewsDigest.com: http://bit.ly/h7emHc

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 460 W. 10th Avenue, Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu